A dual approach for improving homogeneity of a human-type N-glycan structure in Saccharomyces cerevisiae
- PMID: 26983412
- DOI: 10.1007/s10719-016-9656-4
A dual approach for improving homogeneity of a human-type N-glycan structure in Saccharomyces cerevisiae
Abstract
N-glycosylation is an important feature of therapeutic and other industrially relevant proteins, and engineering of the N-glycosylation pathway provides opportunities for developing alternative, non-mammalian glycoprotein expression systems. Among yeasts, Saccharomyces cerevisiae is the most established host organism used in therapeutic protein production and therefore an interesting host for glycoengineering. In this work, we present further improvements in the humanization of the N-glycans in a recently developed S. cerevisiae strain. In this strain, a tailored trimannosyl lipid-linked oligosaccharide is formed and transferred to the protein, followed by complex-type glycan formation by Golgi apparatus-targeted human N-acetylglucosamine transferases. We improved the glycan pattern of the glycoengineered strain both in terms of glycoform homogeneity and the efficiency of complex-type glycosylation. Most of the interfering structures present in the glycoengineered strain were eliminated by deletion of the MNN1 gene. The relative abundance of the complex-type target glycan was increased by the expression of a UDP-N-acetylglucosamine transporter from Kluyveromyces lactis, indicating that the import of UDP-N-acetylglucosamine into the Golgi apparatus is a limiting factor for efficient complex-type N-glycosylation in S. cerevisiae. By a combination of the MNN1 deletion and the expression of a UDP-N-acetylglucosamine transporter, a strain forming complex-type glycans with a significantly improved homogeneity was obtained. Our results represent a further step towards obtaining humanized glycoproteins with a high homogeneity in S. cerevisiae.
Keywords: Glycoengineering; Glycosylation efficiency; MNN1; N-glycosylation; UDP-GlcNAc transporter; Yeast.
Similar articles
-
Disruption of the OCH1 and MNN1 genes decrease N-glycosylation on glycoprotein expressed in Kluyveromyces lactis.J Biotechnol. 2009 Aug 20;143(2):95-102. doi: 10.1016/j.jbiotec.2009.06.016. Epub 2009 Jun 24. J Biotechnol. 2009. PMID: 19559061
-
[Construction of the Man8 GlcNAc2 glycosylation Saccharomyces cerevisiae mutant strain].Wei Sheng Wu Xue Bao. 2007 Oct;47(5):785-9. Wei Sheng Wu Xue Bao. 2007. PMID: 18062249 Chinese.
-
N-glycosylation humanization for production of therapeutic recombinant glycoproteins in Saccharomyces cerevisiae.Methods Mol Biol. 2013;988:45-57. doi: 10.1007/978-1-62703-327-5_4. Methods Mol Biol. 2013. PMID: 23475713
-
The KTR and MNN1 mannosyltransferase families of Saccharomyces cerevisiae.Biochim Biophys Acta. 1999 Jan 6;1426(2):323-34. doi: 10.1016/s0304-4165(98)00133-0. Biochim Biophys Acta. 1999. PMID: 9878809 Review.
-
Asparagine-linked glycosylation in the yeast Golgi.Biochim Biophys Acta. 1999 Jan 6;1426(2):309-22. doi: 10.1016/s0304-4165(98)00132-9. Biochim Biophys Acta. 1999. PMID: 9878803 Review.
Cited by
-
Production of galactosylated complex-type N-glycans in glycoengineered Saccharomyces cerevisiae.Appl Microbiol Biotechnol. 2022 Jan;106(1):301-315. doi: 10.1007/s00253-021-11727-8. Epub 2021 Dec 15. Appl Microbiol Biotechnol. 2022. PMID: 34910238 Free PMC article.
-
Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum.Microb Cell Fact. 2016 May 23;15:87. doi: 10.1186/s12934-016-0488-5. Microb Cell Fact. 2016. PMID: 27216259 Free PMC article.
-
The Impact of Glycoengineering on the Endoplasmic Reticulum Quality Control System in Yeasts.Front Mol Biosci. 2022 Jun 2;9:910709. doi: 10.3389/fmolb.2022.910709. eCollection 2022. Front Mol Biosci. 2022. PMID: 35720120 Free PMC article. Review.
-
Engineering of Yeast Glycoprotein Expression.Adv Biochem Eng Biotechnol. 2021;175:93-135. doi: 10.1007/10_2018_69. Adv Biochem Eng Biotechnol. 2021. PMID: 30397726
-
Mining Data From Plasma Cell Differentiation Identified Novel Genes for Engineering of a Yeast Antibody Factory.Front Bioeng Biotechnol. 2020 Mar 31;8:255. doi: 10.3389/fbioe.2020.00255. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32296695 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases